Related references
Note: Only part of the references are listed.Outcomes in patients with systemic sclerosis undergoing early vs delayed intervention with potential disease-modifying therapies
Keina Yomono et al.
RHEUMATOLOGY (2022)
Current advances in the treatment of systemic sclerosis
Heather Bukiri et al.
CURRENT OPINION IN PHARMACOLOGY (2022)
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG)
Marc Humbert et al.
EUROPEAN HEART JOURNAL (2022)
Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials
Elizabeth R Volkmann et al.
Lancet Rheumatology (2022)
Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts
Sophie I E Liem et al.
Lancet Rheumatology (2022)
Clinical Features of Systemic Sclerosis-Mixed Connective Tissue Disease and Systemic Sclerosis Overlap Syndromes
Jessica L. Fairley et al.
ARTHRITIS CARE & RESEARCH (2021)
The burden of systemic sclerosis in Switzerland the Swiss systemic sclerosis EUSTAR cohort
Jasmin Hernandez et al.
SWISS MEDICAL WEEKLY (2021)
How do patients with systemic sclerosis experience currently provided healthcare and how should we measure its quality?
Julia Spierings et al.
RHEUMATOLOGY (2020)
Gender-related differences in systemic sclerosis
Michael Hughes et al.
AUTOIMMUNITY REVIEWS (2020)
Prognostic properties of anti-topoisomerase antibodies in patients identified by the ACR/EULAR 2013 systemic sclerosis criteria
Maaike Boonstra et al.
RHEUMATOLOGY (2019)
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis
Vincent Sobanski et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort
Anna-Maria Hoffmann-Vold et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Optimal care for systemic sclerosis patients: recommendations from a patient-centered and multidisciplinary mixed-method study and working conference
Julia Spierings et al.
CLINICAL RHEUMATOLOGY (2019)
Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis
Jessica Meijs et al.
RMD OPEN (2016)
Systemic sclerosis
Yannick Allanore et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative
Frank van den Hoogen et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study
S. I. Nihtyanova et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology
RM Lang et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2005)
European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score
G Valentini et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Share Paper
